Atrium Therapeutics reported earnings of -$ 0.25 per RNA share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.81 |
| Earnings Per Share (Surprise) | -$ 0.25 (+$ 0.5609) |
| Last Year's EPS | -$ 0.76 |
| EPS YoY Change |
Out of the last 14 earnings reporting periods, Atrium Therapeutics beat analysts’ expectations 10 times and fell short of expectations 3 time(s). Atrium Therapeutics reported earnings per share of -$ 0.25 in the last report surpassing an estimated EPS of -$ 0.81 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.81 | -$ 0.25 | -$ 0.90 | |
| Aug 13, 2026 | -$ 1.42 | -$ 1.18 | -$ 0.80 | |
| May 14, 2026 | -$ 1.05 | -$ 0.97 | -$ 0.65 | |
| Feb 26, 2026 | -$ 1.24 | -$ 0.61 | -$ 0.65 | |
| May 8, 2025 | -$ 0.90 | -$ 0.90 | -$ 0.79 | |
| Feb 27, 2025 | -$ 0.79 | -$ 0.80 | -$ 0.79 | |
| Nov 7, 2024 | -$ 0.71 | -$ 0.65 | -$ 0.71 | |
| Aug 9, 2024 | -$ 0.79 | -$ 0.65 | -$ 0.66 | |
| May 9, 2024 | -$ 0.78 | -$ 0.79 | -$ 0.74 | |
| Feb 28, 2024 | -$ 0.66 | -$ 0.79 | -$ 0.88 | |
| Nov 8, 2023 | -$ 0.77 | -$ 0.71 | - | - |
| Aug 8, 2023 | -$ 0.80 | -$ 0.66 | - | - |
| May 9, 2023 | -$ 0.85 | -$ 0.74 | - | - |
| Feb 28, 2023 | -$ 0.89 | -$ 0.88 | - | - |
Atrium Therapeutics’s stock was trading at $ 7.96 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, RNA’s price decreased to $ 7.51 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.25 | $ 7.96 | $ 7.51 | |
| Aug 13, 2026 | -$ 1.18 | $ 12.17 | $ 12.84 | |
| May 14, 2026 | -$ 0.97 | $ 13.30 | $ 13.23 | |
| Feb 26, 2026 | -$ 0.61 | $ 14.75 |
Atrium Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Atrium Therapeutics beat analysts’ expectations during the last earnings period by
